Australia Warns of Fake Rabies Vaccine in India; Manufacturer Disputes Scope

Australia has issued an advisory regarding counterfeit Abhayrab rabies vaccine batches in India, urging travelers to seek replacement doses. Manufacturer Indian Immunologicals Limited (IIL) refutes the broad warning, stating the issue was a single, identified, and removed counterfeit batch.

• Australia's ATAGI issued an advisory on counterfeit Abhayrab rabies vaccine in India.
• Advisory urges travelers vaccinated in India since Nov 2023 to seek replacement doses.
• Indian Immunologicals Limited (IIL) refutes advisory as 'over-cautionary'.
• IIL states the issue was one counterfeit batch, identified in Jan 2025 and removed.
• Delhi Drugs Control also flagged the specific counterfeit batch (KA24014) in March 2025.
• Rabies is fatal; prompt and effective vaccination is critical, especially in India.

Read the full story on Quick Digest.